Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

The Institut Pasteur and Merieux Alliance Company Profile

18:15 EDT 24th April 2014 | BioPortfolio

The Institut Pasteur is one of the world's leading biomedical research centre. Founded by Louis Pasteur in 1887, it is a private, non-profit foundation dedicated to the prevention and treatment of diseases through biological research, education and public-health activities. Close to 2,600 people work on its campus in Paris, where a large part of its research activities are devoted to infectious diseases and 10% focuses on AIDS research. The Paris institute is the heart of an International Network made up that unites 30 institutes across all five continents. Over a period of 120 years, 10 Institut Pasteur researchers have received the Nobel Prize, the latest of these in 2008, when it was awarded to Professors Francoise Barre-Sinoussi and Luc Montagnier for the discovery of the Aids virus.


News Articles [590 Associated News Articles listed on BioPortfolio]

Inserm and the Institut Pasteur identify a new variant of Ebola virus in Guinea

(INSERM (Institut national de la santé et de la recherche médicale)) In an article which appeared in The New England journal of Medicine on 16 April, researchers from Inserm and the Institut Pasteur...

ILiAD Biotechnologies LLC, Institut National de la Sante et de la Recherche Medicale (INSERM), Institut Pasteur, National University of Singapore, University of Ireland Maynooth deal

Chemotherapy: When our intestinal bacteria provide reinforcement

(INSERM (Institut national de la santé et de la recherche médicale)) Research jointly conducted by investigators at Institut Gustave Roussy, Inserm, Institut Pasteur and French National Agronomic Re...

Results published from landmark study of immune response

Institut Pasteur and Myriad RBM, a wholly-owned subsidiary of Myriad Genetics, Inc., have announced that they have published an initial data analysis from the landmark Milieu Interieur Project in the...

Research & development for diseases of the poor: A 10-year analysis of impact of the DNDi model

(Drugs for Neglected Diseases Initiative) Today, at a scientific meeting at Institut Pasteur, France, entitled 'Best Science for the Most Neglected: Where Do We Stand Ten Years On?', co-organized with...

Institut Pasteur and Myriad RBM publish results from landmark study of immune response

(Myriad Genetics, Inc.) Institut Pasteur and Myriad RBM, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced they have published an initial data analysis from the landmark Milieu Inter...

ILiAD, Inserm and IPL sign worldwide license agreement for Bordetella pertussis vaccine technology

ILiAD Biotechnologies, LLC, the French National Institute of Health and Medical Research subsidiary, Inserm Transfert SA, and Institut Pasteur de Lille today announced the signing of scientific collab...

University of Melbourne and Sanofi Pasteur to develop human vaccines

Sanofi Pasteur has signed a vaccine development agreement with the University of Melbourne. The alliance was facilitated by UoM Commercial, the university’s commercial engagement services compan...

PubMed Articles [95 Associated PubMed Articles listed on BioPortfolio]

Another year of microbial pathogens and the host immune response.

The associations among improvement and alliance expectations, alliance during treatment, and treatment outcome for major depressive disorder.

Abstract Objective: To examine the associations between treatment/outcome expectations, alliance before and during treatment, and the impact of alliance on symptomatic improvement. Methods: One hundre...

Rules of Engagement: Qualitative Experiences of Therapeutic Alliance When Receiving In-Patient Treatment for Anorexia Nervosa.

Recent research has emphasised the importance of therapeutic alliance to treatment outcomes for anorexia nervosa. This study aimed to examine the experiences of service users in developing therapeutic...

Leishmania epidemiology, diagnosis, chemotherapy and vaccination approaches in the international network of Pasteur Institutes.

Protozoan parasites of the genus Leishmania generate severe human diseases termed leishmaniases. Due to their frequency and the severity of certain clinical forms, these diseases represent a major pub...

California Psychotherapy Alliance Scale (CALPAS): Psychometric properties of the German version for group and individual therapy patients.

Valid and internationally used instruments measuring therapeutic alliance are fundamental for psychotherapy research and practice. The main goal of this study was to validate a German version of the C...

Clinical Trials [50 Associated Clinical Trials listed on BioPortfolio]

Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

Primary objectives: - To describe the immune response to each dengue serotype before and after each vaccination with sanofi pasteur's CYD dengue vaccine. - To evaluate t...

Intervention to Reduce Injection Drug Use

This is a five-year prospective randomized trial comparing two intervention conditions designed to facilitate substance abuse treatment entry and enhance retention in order to reduce the b...

Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand

The present clinical study will assess the immunogenicity and reactogenicity of Sanofi Pasteur's DTacP-IPV// PRP~T combined vaccine (Pentavac™ or Pentaxim™) as a three-dose primary vac...

Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV

The present clinical study will assess the immunogenicity and reactogenicity of Sanofi Pasteur's DTaP-IPV combined vaccines as a three-dose primary vaccination at 2, 4 and 6 months of age...

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects

This trial will evaluate the use of a tetravalent vaccine against dengue. Primary objectives: - To describe the immune response to dengue before and after each vaccination with...

Companies [454 Associated Companies listed on BioPortfolio]

The Institut Pasteur and Merieux Alliance

The Institut Pasteur is one of the world's leading biomedical research centre. Founded by Louis Pasteur in 1887, it is a private, non-profit foundation dedicated to the prevention and treatment of...

institut merieux

With extensive experience in industrial microbiology, Institut Merieux contributes to serving medicine and public health across the globe. For the fight against infectious diseases and cancer, it...

Institut Pasteur

The Institut Pasteur is a non-profit foundation dedicated to the prevation and treatment of diseases through biological research,education and public health activites

Sanofi Pasteur MSD AG

Sanofi Pasteur MSD is the only European company dedicated exclusively to vaccines and was founded in 1994, as a joint venture between Sanofi Pasteur and Merck and Co. Inc.Sanofi Pasteur MSD develops v...

Parteurop

Parteurop is a partner of choice in the life sciences business thanks to its seasoned, experienced team and its international network.Parteurop’s core practices are focused on consulting, private eq...

More Information about "The Institut Pasteur and Merieux Alliance" on BioPortfolio

We have published hundreds of The Institut Pasteur and Merieux Alliance news stories on BioPortfolio along with dozens of The Institut Pasteur and Merieux Alliance Clinical Trials and PubMed Articles about The Institut Pasteur and Merieux Alliance for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Institut Pasteur and Merieux Alliance Companies in our database. You can also find out about relevant The Institut Pasteur and Merieux Alliance Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement